alpha-1-antitrypsin
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
12
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
9
A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha 1 antitrypsin deficiency and non alpha 1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
8
Expression of the alpha 1 antitrypsin gene in mononuclear phagocytes of normal and alpha 1 antitrypsin deficient individuals
11
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
12
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
14
Z type alpha 1 antitrypsin is less competent than M1 type alpha 1 antitrypsin as an inhibitor of neutrophil elastase
10
Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
5
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
10
Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
6
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
9
The prevalence of alpha 1 antitrypsin deficiency in Ireland
7
Description of 22 new alpha-1 antitrypsin genetic variants
7
Mechanism of Inhibition of Porcine Elastase by Human Alpha 1 Antitrypsin
11
Interrelationships between the Human Alveolar Macrophage and Alpha 1 Antitrypsin
8
Alpha -1-antitrypsin deficiency, associated diseases and treatments: a review
7
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
9
The prevalence of alpha-1 antitrypsin deficiency in Ireland
7
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
9
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
14